Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients Academic Article Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Murine-Derived
  • Lymphoma, Follicular
  • Radioimmunotherapy
  • T-Lymphocyte Subsets
  • T-Lymphocytes

abstract

  • The pharmacokinetics of antistromal mAbF19 were well defined in these two studies with different solid tumour types, and were comparable with those of other murine monoclonal antibodies that do not bind to normal tissue antigens or blood cells.

publication date

  • March 26, 2001

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1046/j.1365-2125.2001.01335.x

PubMed ID

  • 11259992

Additional Document Info

start page

  • 177

end page

  • 80

volume

  • 51

number

  • 2